Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-;which typically causes mild, cold-like symptoms in most adults but can be deadly for infants-;during weeks 32–36 of pregnancy.
Lykos takes another hit as ICER lays out ‘insufficient’ evidence for MDMA-based treatment
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
June 28, 2024